Committee Chairman Sen. Chuck Grassley, R-Iowa, and ranking member Sen. Ron Wyden, D-Ore., invited leaders from AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck, Pfizer and Sanofi.
The four executives scheduled to attend the Feb. 26 hearing are: Bristol Myers CEO Giovanni Caforio, MD; Merck CEO Ken Frazier; Pfizer CEO Albert Bourla, PhD; and Sanofi CEO Olivier Brandicourt, MD.
The other three drugmakers didn’t immediately respond to the invite.
The Senate Finance Committee held an initial hearing on drug prices in January. During the hearing, Mr. Grassley expressed disappointment about drug executives’ lack of attendance and commented he would be “more insistent” that executives show up at a subsequent meeting.
More articles on pharmacy:
Senate committee invites 7 pharma leaders to testify at drug price hearing
Bernie Sanders takes aim at drug’s $375K price tag
Walgreens buys 63 pharmacies out of bankruptcy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
